Acute Respiratory Distress Syndrome (ARDS): Mechanism

1. Triggers and Initial Insult

2. Diffuse Alveolar Damage (DAD) — The Pathologic Hallmark

Exudative Phase (Days 1–7)

• Alveolar-capillary membrane disruption: Both the microvascular endothelium and alveolar epithelium (especially type I pneumocytes) are injured and killed (via necrosis, apoptosis, and mechanical stretch). Loss of this barrier allows protein-rich fluid to flood the alveolar space.
• Hyaline membrane formation: Leaked plasma proteins (fibrin, immunoglobulins) and cellular debris line the alveolar walls, forming the characteristic eosinophilic hyaline membranes seen on histology.
• Pulmonary edema: Increased permeability — not elevated hydrostatic pressure — is the defining feature distinguishing ARDS from cardiogenic pulmonary edema.

Proliferative Phase (Days 7–21)

• Type II pneumocytes proliferate in an attempt to resurface the denuded alveolar epithelium and restore barrier function.
• Fibroblast migration and early collagen deposition begin (elevated N-terminal procollagen III peptide can be detected in BAL fluid within 24 hours of onset).

Fibrotic Phase (>3 weeks)

• Some patients develop progressive fibrosis with architectural distortion, leading to chronic respiratory failure and an increased risk of barotrauma.

Left: CT showing bilateral ground-glass opacities. Right: H&E histology showing thickened alveolar walls and hyaline membranes (arrow) — the hallmark of diffuse alveolar damage.

3. Neutrophil-Mediated Injury — Central Mechanism

• Pulmonary capillaries (~5 µm diameter) are narrower than neutrophils (~7–8 µm), forcing neutrophils to deform to transit the capillary bed. Activated, less deformable neutrophils become mechanically trapped.
• Simultaneously, upregulation of adhesion molecules (ICAM-1, E-selectin, P-selectin) on endothelial cells promotes neutrophil rolling and firm adhesion via integrin-ICAM interactions.

• Systemic inflammatory signals (TNF-α, IL-1β, IL-6, IL-8) from the primary insult activate circulating neutrophils and recruit them to the lung.
• IL-8 (a potent neutrophil chemoattractant) is markedly elevated in BAL fluid of ARDS patients.

• Reactive oxygen species (ROS): Superoxide, hydrogen peroxide, and hydroxyl radicals directly oxidize and damage endothelial and epithelial cell membranes.
• Proteolytic enzymes: Leukocyte elastase degrades the extracellular matrix (collagen, fibronectin, elastin) and also degrades surfactant protein A, amplifying alveolar dysfunction.
• Cytokines and chemokines: Activated neutrophils release TNF-α, IL-1β, and additional IL-8, amplifying the local inflammatory cascade.
• Neutrophil extracellular traps (NETs): Chromatin and granule proteins extruded from neutrophils contribute to microvascular thrombosis and further tissue injury.

Murray & Nadel's Fig. 134.3 — PMNs exit the capillary lumen, cross the alveolar-capillary membrane, and release elastase, ROS, cytokines, and NETs. This drives epithelial injury and edema.

4. Surfactant Dysfunction

• Injury to type II pneumocytes reduces synthesis of surfactant phospholipids (dipalmitoylphosphatidylcholine, phosphatidylglycerol).
• Leaked plasma proteins in the alveolar space inhibit surfactant function.
• Neutrophil elastase degrades surfactant protein A, further impairing the innate defense and surface tension reduction roles of surfactant.
• The ratio of large (biologically active) to small (inactive) surfactant aggregates is diminished.
• Consequence: Increased alveolar surface tension → diffuse microatelectasis → worsening ventilation-perfusion (V/Q) mismatch and intrapulmonary shunt.

5. Coagulation and Microvascular Thrombosis

• The alveolar space in ARDS becomes pro-coagulant: elevated tissue factor expression on injured epithelial cells, activated macrophages, and monocytes drives intra-alveolar fibrin deposition.
• Simultaneously, fibrinolysis is suppressed (elevated plasminogen activator inhibitor-1, PAI-1), leading to persistent fibrin clots that incorporate into hyaline membranes.
• Microvascular thrombosis compromises perfusion of lung units and can extend the zone of injury.

6. Impaired Alveolar Fluid Clearance

• Normal alveolar epithelium clears fluid by active sodium transport (via apical ENaC channels on type I/II pneumocytes and basolateral Na⁺/K⁺-ATPase), which drives osmotic water removal.
• In ARDS, epithelial injury impairs this sodium-driven fluid clearance — fluid accumulates faster than it can be removed.
• Clinical studies show that preserved or elevated alveolar fluid clearance is associated with improved survival, and impaired clearance predicts worse outcomes.

7. Angiopoietins and Endothelial Stability

• Angiopoietin-1 (Ang1) activates the Tie2 receptor on endothelium, stabilizing junctional integrity and reducing permeability.
• Angiopoietin-2 (Ang2) is stored in Weibel-Palade bodies and rapidly released upon endothelial activation; it antagonizes Tie2, promoting vascular leakage and inflammation.
• In ARDS, Ang2 levels are markedly elevated in plasma, correlating with severity and mortality. This Ang1/Ang2 imbalance is now a therapeutic target under investigation.

8. Ventilator-Induced Lung Injury (VILI)

9. Net Physiologic Consequences

1. Intrapulmonary shunt (V/Q = 0): Fluid-filled, consolidated alveoli are perfused but not ventilated → severe hypoxemia refractory to supplemental O₂.
2. Reduced lung compliance: Edema, atelectasis, and hyaline membranes stiffen the lung → high work of breathing, high driving pressures.
3. Increased dead space (V/Q → ∞): Microvascular thrombosis and vasoconstriction reduce perfusion to ventilated units → hypercapnia in severe disease.

Summary Diagram (Conceptual)

Primary Insult (sepsis, pneumonia, aspiration, trauma)
         ↓
Systemic inflammatory activation (TNF-α, IL-1β, IL-6, IL-8)
         ↓
Neutrophil sequestration in pulmonary microvasculature
         ↓
Neutrophil transmigration → ROS + elastase + NETs + cytokines
         ↓
Endothelial + epithelial injury (Ang2 ↑, Tie2 destabilized)
         ↓
Alveolar-capillary barrier breakdown
         ↓
Protein-rich edema floods alveoli + hyaline membrane formation
         ↓ 
Surfactant dysfunction → microatelectasis
         ↓
V/Q mismatch + intrapulmonary shunt + ↓ compliance
         ↓
Hypoxemic respiratory failure (ARDS)
         ↓
VILI (if mechanically ventilated with injurious strategy)
         ↓
Biotrauma → multi-organ failure

• Murray & Nadel's Textbook of Respiratory Medicine, Chapter 134 (ARDS: Etiology, Pathogenesis, Treatment)
• Goldman-Cecil Medicine, Chapter 91 (Mechanical Ventilation in ARDS)
• Sabiston Textbook of Surgery, Chapter on Critical Care